Aclaris Therapeutics, Inc. (ACRS) Social Stream
ACLARIS THERAPEUTICS INC (ACRS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ACRS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-20 | 4 | $50 | $26 | $34 | $6.65 | 411.28% |
| 2022-08-01 | 5 | $50 | $26 | $34.8 | $6.65 | 423.31% |
| 2022-08-08 | 6 | $50 | $26 | $34.8 | $6.65 | 423.31% |
| 2022-10-06 | 6 | $50 | $26 | $34.333 | $6.65 | 416.29% |
| 2022-11-09 | 7 | $50 | $26 | $34.333 | $6.65 | 416.29% |
| 2022-12-01 | 8 | $50 | $25 | $33 | $6.65 | 396.24% |
| 2023-02-24 | 9 | $50 | $25 | $32.5 | $6.65 | 388.72% |
| 2023-03-01 | 9 | $50 | $25 | $33.5 | $6.65 | 403.76% |
| 2023-03-07 | 9 | $43 | $11 | $30 | $6.65 | 351.13% |
| 2023-05-08 | 9 | $43 | $11 | $29.125 | $6.65 | 337.97% |
| 2023-08-08 | 9 | $43 | $16 | $29.375 | $6.65 | 341.73% |
| 2023-09-19 | 9 | $43 | $20 | $29.875 | $6.65 | 349.25% |
The Trend in the Analyst Price Target
ACRS's average price target has moved down $4.46 over the prior 45 weeks.
ACRS reports an average of 183.7% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-14 | 9 | 50 | 25 | 32.500 | 16.17 | 100.99% |
| 2023-02-24 | 9 | 50 | 25 | 32.500 | 12.07 | 169.26% |
| 2023-02-24 | 9 | 50 | 25 | 32.875 | 12.07 | 172.37% |
| 2023-03-01 | 9 | 50 | 25 | 33.500 | 12.24 | 173.69% |
| 2023-03-09 | 9 | 43 | 11 | 29.125 | 7.66 | 280.22% |
ACRS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 9 | 0 | 0 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 21 months, ACRS's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ACRS has a greater upside potential (average analyst target price relative to current price) than 1367.44% of all US stocks.
- In terms of how ACLARIS THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1096.24% of that group.
- In the context of stocks in the small market cap category, ACLARIS THERAPEUTICS INC's number of analysts covering the stock is greater than 1230.6% of them.
- In the context of stocks in the small market cap category, ACLARIS THERAPEUTICS INC's average analyst price target is higher than 1156.44% of them.
Stocks similar to ACLARIS THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are WVE, ALPN, and IMMP.
View All Top Stocks by Price Target
Is ACRS a Buy, Hold or Sell? See the POWR Ratings now!